Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Albrecht

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 30, 2023
Long-term potentiation-like plasticity is retained during relapse in patients with Multiple SclerosisCarolin Balloff, Sveva Novello, Arved-Sebastian Stucke, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, et al.
Frontiers in Neurology|September 25, 2020
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple SclerosisKatharina Breitkopf, Aykut Aytulun, Moritz Förster, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled studyWolf A Lagrèze, Sebastian Küchlin, Gabriele Ihorst, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Journal of Visualized Experiments : Jove|October 23, 2023
Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis MiceChristina B Schroeter, Antonia Henes, Anna Vogelsang, et al.
Multiple Sclerosis and Related Disorders|March 8, 2026
Altered network recruitment in multiple sclerosis patients during resting stateAnnika Lüttjohann, Saskia Räuber, Melanie Korsen, et al.
Annals of Clinical and Translational Neurology|September 5, 2015
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher diseaseDirk B Epplen, Thomas Prukop, Tobias Nientiedt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2021
CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy: Subtle Retinal Changes in Optical Coherence TomographyJens Ingwersen, Jonas Graf, Julia Kluge, et al.
Frontiers in Immunology|March 20, 2025
Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosisMustafa Sindi, Michael Dietrich, Diana Klees, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 30, 2023
Long-term potentiation-like plasticity is retained during relapse in patients with Multiple SclerosisCarolin Balloff, Sveva Novello, Arved-Sebastian Stucke, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, et al.
Frontiers in Neurology|September 25, 2020
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple SclerosisKatharina Breitkopf, Aykut Aytulun, Moritz Förster, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled studyWolf A Lagrèze, Sebastian Küchlin, Gabriele Ihorst, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Journal of Visualized Experiments : Jove|October 23, 2023
Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis MiceChristina B Schroeter, Antonia Henes, Anna Vogelsang, et al.
Multiple Sclerosis and Related Disorders|March 8, 2026
Altered network recruitment in multiple sclerosis patients during resting stateAnnika Lüttjohann, Saskia Räuber, Melanie Korsen, et al.
Annals of Clinical and Translational Neurology|September 5, 2015
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher diseaseDirk B Epplen, Thomas Prukop, Tobias Nientiedt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2021
CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy: Subtle Retinal Changes in Optical Coherence TomographyJens Ingwersen, Jonas Graf, Julia Kluge, et al.
Frontiers in Immunology|March 20, 2025
Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosisMustafa Sindi, Michael Dietrich, Diana Klees, et al.
Pageof 17